Evaluation Of Safety, Tolerability And Pharmacokinetics Of Single And Multiple Doses Of Compound PF-06823859
Status:
Completed
Trial end date:
2017-09-26
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety, tolerability and pharmacokinetics of
escalating single and multiple intravenous (IV) infusions and subcutaneous (SC) injections of
PF 06823859 in healthy subjects.